https://stock.noler.com/us/stock/zs-pharma-inc https://stock.noler.com/us/stock/zs-pharma-inc/accounts-payable https://stock.noler.com/us/stock/zs-pharma-inc/accounts-payable-other-current https://stock.noler.com/us/stock/zs-pharma-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/zs-pharma-inc/accrued-income-taxes https://stock.noler.com/us/stock/zs-pharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/zs-pharma-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/zs-pharma-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/zs-pharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/zs-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/zs-pharma-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/zs-pharma-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/zs-pharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/zs-pharma-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/zs-pharma-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/zs-pharma-inc/amortization-of-lease-incentives https://stock.noler.com/us/stock/zs-pharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/zs-pharma-inc/aoci https://stock.noler.com/us/stock/zs-pharma-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/zs-pharma-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/zs-pharma-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/zs-pharma-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/zs-pharma-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/zs-pharma-inc/business-exit-costs https://stock.noler.com/us/stock/zs-pharma-inc/capital-expenditures https://stock.noler.com/us/stock/zs-pharma-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/zs-pharma-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/zs-pharma-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/zs-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/zs-pharma-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/zs-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/zs-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zs-pharma-inc/common-stock-value https://stock.noler.com/us/stock/zs-pharma-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/zs-pharma-inc/contractual-obligation https://stock.noler.com/us/stock/zs-pharma-inc/contribution-of-property https://stock.noler.com/us/stock/zs-pharma-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/zs-pharma-inc/costs-and-expenses https://stock.noler.com/us/stock/zs-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/zs-pharma-inc/current-assets https://stock.noler.com/us/stock/zs-pharma-inc/current-liabilities https://stock.noler.com/us/stock/zs-pharma-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/zs-pharma-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/zs-pharma-inc/debt-face-amount https://stock.noler.com/us/stock/zs-pharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/zs-pharma-inc/debt-issued https://stock.noler.com/us/stock/zs-pharma-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zs-pharma-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/zs-pharma-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/zs-pharma-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/zs-pharma-inc/depreciation https://stock.noler.com/us/stock/zs-pharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/zs-pharma-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/zs-pharma-inc/derivative-liabilities https://stock.noler.com/us/stock/zs-pharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/zs-pharma-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/zs-pharma-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/zs-pharma-inc/form-d-other https://stock.noler.com/us/stock/zs-pharma-inc/form-d-stocks https://stock.noler.com/us/stock/zs-pharma-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/zs-pharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/zs-pharma-inc/held-to-maturity-securities-unrealized-loss-position-twelve-months-or-longer-fair-value https://stock.noler.com/us/stock/zs-pharma-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/zs-pharma-inc/incentive-from-lessor https://stock.noler.com/us/stock/zs-pharma-inc/income-tax https://stock.noler.com/us/stock/zs-pharma-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/zs-pharma-inc/income-taxes-paid https://stock.noler.com/us/stock/zs-pharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/zs-pharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/zs-pharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/zs-pharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/zs-pharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/zs-pharma-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/zs-pharma-inc/interest-and-other-income https://stock.noler.com/us/stock/zs-pharma-inc/interest-expense https://stock.noler.com/us/stock/zs-pharma-inc/interest-expense-other https://stock.noler.com/us/stock/zs-pharma-inc/interest-income-other https://stock.noler.com/us/stock/zs-pharma-inc/interest-paid https://stock.noler.com/us/stock/zs-pharma-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/zs-pharma-inc/investment-income-interest https://stock.noler.com/us/stock/zs-pharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/zs-pharma-inc/lease-incentive-payable-current-and-noncurrent https://stock.noler.com/us/stock/zs-pharma-inc/level-3-instruments-classified-in-shareholders-equity-change https://stock.noler.com/us/stock/zs-pharma-inc/level-3-instruments-classified-in-shareholders-equity-transfers-net https://stock.noler.com/us/stock/zs-pharma-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/zs-pharma-inc/level-3-liability-issues https://stock.noler.com/us/stock/zs-pharma-inc/liability-for-uncertain-tax-positions-noncurrent https://stock.noler.com/us/stock/zs-pharma-inc/long-term-debt https://stock.noler.com/us/stock/zs-pharma-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/zs-pharma-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/zs-pharma-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/zs-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/zs-pharma-inc/net-income https://stock.noler.com/us/stock/zs-pharma-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/zs-pharma-inc/oci-net-of-tax https://stock.noler.com/us/stock/zs-pharma-inc/operating-income https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/zs-pharma-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/zs-pharma-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/zs-pharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/zs-pharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/zs-pharma-inc/other-current-assets https://stock.noler.com/us/stock/zs-pharma-inc/other-noncash-income-expense https://stock.noler.com/us/stock/zs-pharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/zs-pharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/zs-pharma-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/zs-pharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/zs-pharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/zs-pharma-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/zs-pharma-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/zs-pharma-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/zs-pharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/zs-pharma-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/zs-pharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/zs-pharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/zs-pharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/zs-pharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/zs-pharma-inc/preferred-stock-value https://stock.noler.com/us/stock/zs-pharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-long-term-capital-lease-obligations https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-sale-maturity-and-collection-of-shortterm-investments https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/zs-pharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/zs-pharma-inc/profit-loss https://stock.noler.com/us/stock/zs-pharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/zs-pharma-inc/property-plant-equipment https://stock.noler.com/us/stock/zs-pharma-inc/public-float https://stock.noler.com/us/stock/zs-pharma-inc/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/zs-pharma-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/zs-pharma-inc/research-and-development https://stock.noler.com/us/stock/zs-pharma-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/zs-pharma-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/zs-pharma-inc/restricted-stock-expense https://stock.noler.com/us/stock/zs-pharma-inc/retained-earnings https://stock.noler.com/us/stock/zs-pharma-inc/royalty-expense https://stock.noler.com/us/stock/zs-pharma-inc/sga-expense https://stock.noler.com/us/stock/zs-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/zs-pharma-inc/shares-authorized https://stock.noler.com/us/stock/zs-pharma-inc/shares-issued https://stock.noler.com/us/stock/zs-pharma-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/zs-pharma-inc/short-term-investments https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/zs-pharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/zs-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/zs-pharma-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/zs-pharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/zs-pharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/zs-pharma-inc/stock-issued-shares-issued-shares-share-based-compensation-forfeited https://stock.noler.com/us/stock/zs-pharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/zs-pharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/zs-pharma-inc/stock-option-plan-expense https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/zs-pharma-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/zs-pharma-inc/stock-split-ratio https://stock.noler.com/us/stock/zs-pharma-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/zs-pharma-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/zs-pharma-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/zs-pharma-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/zs-pharma-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/zs-pharma-inc/tax-reconciliation-tax-contingencies-state-and-local https://stock.noler.com/us/stock/zs-pharma-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/zs-pharma-inc/total-assets https://stock.noler.com/us/stock/zs-pharma-inc/total-liabilities https://stock.noler.com/us/stock/zs-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/zs-pharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/zs-pharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted